Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: Results from the European randomized study of screening for prostate cancer section Rotterdam Academic Article uri icon

Overview

MeSH Major

  • Decision Support Techniques
  • Kallikreins
  • Prostate-Specific Antigen
  • Prostatectomy
  • Prostatic Neoplasms
  • Tissue Kallikreins

abstract

  • Our study provided proof of principle that predictions based on levels of four kallikrein markers in blood distinguish between pathologically insignificant and aggressive disease after RP with good accuracy. In the future, clinical use of the model could potentially reduce rates of immediate unnecessary active treatment.

publication date

  • November 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3786059

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2013.04.040

PubMed ID

  • 23683475

Additional Document Info

start page

  • 693

end page

  • 9

volume

  • 64

number

  • 5